Platinum Press Inc. (PPI), a provider of printed packaging solutions, has completed a $15 million expansion and ...

Adheres to requirements, including 21 CFR Part 820 and Good Manufacturing Practices.

The U.S. Food and Drug Administration (FDA) has accepted Sentynl Therapeutics Inc.’s New Drug Application (NDA) for CUTX-101 ...

“Today marks a significant milestone in Halia’s journey,” said Dr. David J. Bearss, President & CEO of Halia Therapeutics.

Nitroxoline has not been approved by the FDA, and its use is therefore considered investigational. FLA patients will receive ...

The KOASTAL-1 study enrolled 383 adult patients with MDD. Navacaprant was shown to be safe and generally well-tolerated with ...

Innovent Biologics Inc., a biopharmaceutical company that develops, manufactures and commercializes medicines, has entered a ...

Chime Biologics, a global CDMO, and Mabgeek, a clinical-stage innovative antibody drug development biotech, have successfully ...

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, has appointed Lori ...

Veeda Group has unveiled a new logo and brand identity— Veeda Lifesciences —reflecting the brand’s evolution from a ...

WuXi Biologics plans to sell its vaccine facility in Dundalk, Ireland to Merck & Co. for approximately $500 million. This ...

Sangamo plans to explore all options to commercialize the Hemophilia A asset.